{
    "Trade/Device Name(s)": [
        "Assure@ Pro Blood Glucose Monitoring System",
        "Assure@ Pro Blood Glucose Meter",
        "Assure Pro Test Strips",
        "Assure Pro Level 1 Control Solution",
        "Assure\u00ae Pro Level 2 Control Solution"
    ],
    "Submitter Information": "Hypoguard USA, Inc.",
    "510(k) Number": "K051514",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "October 4, 2005",
    "Summary Letter Received Date": "September 27, 2005",
    "Submission Date": "September 23, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Single (specified) analyte controls (assayed/unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Assure Pro Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Assure Pro Blood Glucose Monitoring System for quantitative measurement of glucose in fresh capillary whole blood",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood for home and clinical use to monitor diabetes control",
    "fda_folder": "Clinical Chemistry"
}